Cargando…
Hepatic stellate cells specific liposomes with the Toll‐like receptor 4 shRNA attenuates liver fibrosis
The hepatic stellate cells (HSCs) play a significant role in the onset of liver fibrosis, which can be treated by the inhibition and reversal of HSC activation. The RNA interference‐mediated TLR4 gene silencing might be a potential therapeutic approach for liver fibrosis. The crucial challenge in th...
Autores principales: | Zhang, Yuwei, Li, Yang, Mu, Tong, Tong, Nanwei, Cheng, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812270/ https://www.ncbi.nlm.nih.gov/pubmed/33336563 http://dx.doi.org/10.1111/jcmm.16209 |
Ejemplares similares
-
Blocking of SMAD4 expression by shRNA effectively inhibits fibrogenesis of human hepatic stellate cells
por: Khanizadeh, Sayyad, et al.
Publicado: (2015) -
Co-Delivery of Doxorubicin and SATB1 shRNA by Thermosensitive Magnetic Cationic Liposomes for Gastric Cancer Therapy
por: Peng, Zhao, et al.
Publicado: (2014) -
Construction of shRNA lentiviral vector
por: Song, Hong, et al.
Publicado: (2010) -
Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells
por: Huang, Yangqing, et al.
Publicado: (2013) -
Thermosensitive Cationic Magnetic Liposomes for Thermoresponsive Delivery of CPT-11 and SLP2 shRNA in Glioblastoma Treatment
por: Lu, Yu-Jen, et al.
Publicado: (2023)